Assura (AGR) Given Buy Rating at Liberum Capital
Separately, Peel Hunt restated a hold rating on shares of Assura in a research report on Tuesday, October 2nd.
LON AGR remained flat at $GBX 56 ($0.73) during trading on Friday. 2,608,264 shares of the company’s stock traded hands, compared to its average volume of 2,800,000. Assura has a twelve month low of GBX 55.95 ($0.73) and a twelve month high of GBX 67.30 ($0.88).
Assura Company Profile
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community.
Featured Story: Leveraged Buyout (LBO)
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.